Recruiting
Phase 1
Phase 2

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT04565665

Conditions

COVID-19 Infection

COVID-19-Associated Acute Respiratory Distress Syndrome

Hematopoietic and Lymphoid Cell Neoplasm

Malignant Solid Neoplasm

Symptomatic COVID-19 Infection Laboratory-Confirmed

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Best Practice

Mesenchymal Stem Cell

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information